news & insights

Market Access Insights

As market access consultants in Belgium, based in Ghent and working across the Benelux, Axes Health helps international pharma and biotech companies navigate that landscape from early strategy through reimbursement and beyond.

These insights explains how the Belgian market access system actually works, what changed in 2026, and how the right approach turns a complex process into a predictable pathway to patients.

Rare Diseases Forum 2026: Innovation & Access

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Start Now

Innovation Access Programs

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Start Now

Fast Access Belgium 2026 Explained

https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Start Now

Belgium Reimbursement Reform

Modernisation of Reimbursement Procedures in Belgium

Start Now

JCA Solutions for European HTA

Joint Clinical Assessment: bridging European assessment with national patient access solutions

Start Now

Rare Diseases Forum 2026: Innovation & Access

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Innovation Access Programs

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Fast Access Belgium 2026 Explained

https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Belgium Reimbursement Reform

Modernisation of Reimbursement Procedures in Belgium

JCA Solutions for European HTA

Joint Clinical Assessment: bridging European assessment with national patient access solutions